Connection
Lia Gore to Prodrugs
This is a "connection" page, showing publications Lia Gore has written about Prodrugs.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.668 |
|
|
|
-
Abdul Razak AR, Miller WH, Uy GL, Blotner S, Young AM, Higgins B, Chen LC, Gore L. A phase 1 study of the MDM2 antagonist RO6839921, a pegylated prodrug of idasanutlin, in patients with advanced solid tumors. Invest New Drugs. 2020 08; 38(4):1156-1165.
Score: 0.668